Last edition
News about "VIVOZON Pharmaceutical "
VIVOZON Pharmaceutical Secures MFDS Approval for UNAFRA Inj.
With this milestone, UNAFRA Inj. has become the 38th innovative drug in Korea. UNAFRA Inj., discovered by using the company's proprietary multi-target drug development platform, is the world's first non-opioid, non-NSAIDS analgesic.
VIVOZON Pharmaceutical | 18/02/2025 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members